<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/2E60EE03-E401-4805-B4A9-DD226392E36D/chart/price-vs-fair-value?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/2E60EE03-E401-4805-B4A9-DD226392E36D/chart/price-vs-fair-value"/></p>
<p>TSE:6508 1 年股价与公允价值</p>
<p>探索来自社区的 Meidensha 公允价值并选择您的观点</p>
<p>对于 <strong>明电舍株式会社</strong>（TSE:6508）的股东来说，这一周过得不错，因为公司刚刚发布了最新的季度业绩，股价上涨了 3.6%，达到了 JP¥5,710。整体结果令人信服，收入为 JP¥58 亿，法定每股收益为 JP¥408，均符合分析师的预期，显示出明电舍的执行与预期一致。盈利是投资者关注的重要时刻，因为他们可以跟踪公司的表现，查看分析师对明年的预测，并观察对公司的情绪是否发生变化。读者会高兴地知道，我们汇总了最新的法定预测，以查看分析师在最新结果后是否改变了对明电舍的看法。</p>
<p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/874354-earnings-and-revenue-growth-1-dark-2/1754354135812?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/874354-earnings-and-revenue-growth-1-dark-2/1754354135812"/></p>
<p>TSE:65082025 年 8 月 5 日的收益和收入增长</p>
<p>考虑到最新的结果，明电舍五位分析师的共识预测是 2026 年收入为 JP¥328.5 亿。这反映出与过去 12 个月相比，收入有令人满意的 7.9% 的增长。法定每股收益预计在同一时期下降 6.5%，降至 JP¥370。在这份盈利报告之前，分析师曾预测 2026 年收入为 JP¥328.6 亿，每股收益（EPS）为 JP¥363。共识分析师似乎没有在这些结果中看到任何会改变他们对业务看法的因素，因为他们的预测没有重大变化。</p>
<p>查看我们对明电舍的最新分析</p>
<p>收入或收益预测以及 JP¥6,160 的价格目标没有变化，这表明公司在最近的结果中达到了预期。共识价格目标只是各个分析师目标的平均值，因此——查看基础估计的范围可能会很有帮助。最乐观的明电舍分析师的价格目标为每股 JP¥7,200，而最悲观的则为 JP¥5,000。正如您所见，分析师对该股票的未来并不完全一致，但估计范围仍然相对狭窄，这可能表明结果并非完全不可预测。</p>
<p>现在从更大的视角来看，我们可以通过将这些预测与过去的表现和行业增长估计进行比较来理解这些预测。分析师们显然预计明电舍的增长将加速，预计到 2026 年底年均增长 11%，与过去五年年均增长 4.9% 相比表现良好。与同一行业的其他公司相比，后者预计年均收入增长 4.6%。显然，尽管增长前景比近期更为光明，但分析师们也预计明电舍的增长速度将快于更广泛的行业。</p>
<h2>结论</h2>
<p>最明显的结论是，最近业务前景没有重大变化，分析师们保持了他们的收益预测，与之前的估计一致。令人高兴的是，收入预测没有重大变化，业务仍然预计将比更广泛的行业增长得更快。共识价格目标没有实质性变化，这表明业务的内在价值在最新估计中没有发生重大变化。</p>
<p>考虑到这一点，我们仍然认为，业务的长期发展轨迹对投资者来说更为重要。我们有来自多位明电舍分析师的预测，直到 2028 年，您可以在我们的平台上免费查看。</p>
<p>不过，您应该始终考虑风险。举个例子，我们发现了 <strong>明电舍的 1 个警告信号</strong>，您应该注意。</p>

6508

<p>美电社（TSE:6508）公布了第一季度业绩，收入为 580 亿日元，每股收益为 408 日元，符合分析师预期。股价上涨 3.6%，达到 5,710 日元。分析师预测 2026 年收入为 3,285 亿日元，增长 7.9%，但预计每股收益将下降 6.5%，降至 370 日元。共识目标价维持在 6,160 日元，估计范围在 5,000 日元至 7,200 日元之间。总体来看，分析师认为美电社的增长速度将快于行业，预计到 2026 年的年增长率为 11%</p>

<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/2E60EE03-E401-4805-B4A9-DD226392E36D/chart/price-vs-fair-value" alt="" original-src="https://images.simplywall.st/company/2E60EE03-E401-4805-B4A9-DD226392E36D/chart/price-vs-fair-value"/></p>
<p>TSE:6508 1 Year Share Price vs Fair Value</p>
<div class="lb-trans"><p>TSE:6508 1 年股价与公允价值</p>
</div><p>Explore Meidensha's Fair Values from the Community and select yours</p>
<div class="lb-trans"><p>探索来自社区的 Meidensha 公允价值并选择您的观点</p>
</div><p>It's been a good week for <strong>Meidensha Corporation</strong> (TSE:6508) shareholders, because the company has just released its latest quarterly results, and the shares gained 3.6% to JP¥5,710. It was a credible result overall, with revenues of JP¥58b and statutory earnings per share of JP¥408 both in line with analyst estimates, showing that Meidensha is executing in line with expectations. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Meidensha after the latest results.</p>
<div class="lb-trans"><p>对于 <strong>明电舍株式会社</strong>（TSE:6508）的股东来说，这一周过得不错，因为公司刚刚发布了最新的季度业绩，股价上涨了 3.6%，达到了 JP¥5,710。整体结果令人信服，收入为 JP¥58 亿，法定每股收益为 JP¥408，均符合分析师的预期，显示出明电舍的执行与预期一致。盈利是投资者关注的重要时刻，因为他们可以跟踪公司的表现，查看分析师对明年的预测，并观察对公司的情绪是否发生变化。读者会高兴地知道，我们汇总了最新的法定预测，以查看分析师在最新结果后是否改变了对明电舍的看法。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/874354-earnings-and-revenue-growth-1-dark-2/1754354135812" alt="" original-src="https://images.simplywall.st/asset/chart/874354-earnings-and-revenue-growth-1-dark-2/1754354135812"/></p>
<p>TSE:6508 Earnings and Revenue Growth August 5th 2025</p>
<div class="lb-trans"><p>TSE:65082025 年 8 月 5 日的收益和收入增长</p>
</div><p>Taking into account the latest results, the consensus forecast from Meidensha's five analysts is for revenues of JP¥328.5b in 2026. This reflects a satisfactory 7.9% improvement in revenue compared to the last 12 months. Statutory earnings per share are expected to decrease 6.5% to JP¥370 in the same period. Before this earnings report, the analysts had been forecasting revenues of JP¥328.6b and earnings per share (EPS) of JP¥363 in 2026. The consensus analysts don't seem to have seen anything in these results that would have changed their view on the business, given there's been no major change to their estimates.</p>
<div class="lb-trans"><p>考虑到最新的结果，明电舍五位分析师的共识预测是 2026 年收入为 JP¥328.5 亿。这反映出与过去 12 个月相比，收入有令人满意的 7.9% 的增长。法定每股收益预计在同一时期下降 6.5%，降至 JP¥370。在这份盈利报告之前，分析师曾预测 2026 年收入为 JP¥328.6 亿，每股收益（EPS）为 JP¥363。共识分析师似乎没有在这些结果中看到任何会改变他们对业务看法的因素，因为他们的预测没有重大变化。</p>
</div><p>Check out our latest analysis for Meidensha</p>
<div class="lb-trans"><p>查看我们对明电舍的最新分析</p>
</div><p>There were no changes to revenue or earnings estimates or the price target of JP¥6,160, suggesting that the company has met expectations in its recent result. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. The most optimistic Meidensha analyst has a price target of JP¥7,200 per share, while the most pessimistic values it at JP¥5,000. As you can see, analysts are not all in agreement on the stock's future, but the range of estimates is still reasonably narrow, which could suggest that the outcome is not totally unpredictable.</p>
<div class="lb-trans"><p>收入或收益预测以及 JP¥6,160 的价格目标没有变化，这表明公司在最近的结果中达到了预期。共识价格目标只是各个分析师目标的平均值，因此——查看基础估计的范围可能会很有帮助。最乐观的明电舍分析师的价格目标为每股 JP¥7,200，而最悲观的则为 JP¥5,000。正如您所见，分析师对该股票的未来并不完全一致，但估计范围仍然相对狭窄，这可能表明结果并非完全不可预测。</p>
</div><p>Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. The analysts are definitely expecting Meidensha's growth to accelerate, with the forecast 11% annualised growth to the end of 2026 ranking favourably alongside historical growth of 4.9% per annum over the past five years. Compare this with other companies in the same industry, which are forecast to grow their revenue 4.6% annually. It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect Meidensha to grow faster than the wider industry.</p>
<div class="lb-trans"><p>现在从更大的视角来看，我们可以通过将这些预测与过去的表现和行业增长估计进行比较来理解这些预测。分析师们显然预计明电舍的增长将加速，预计到 2026 年底年均增长 11%，与过去五年年均增长 4.9% 相比表现良好。与同一行业的其他公司相比，后者预计年均收入增长 4.6%。显然，尽管增长前景比近期更为光明，但分析师们也预计明电舍的增长速度将快于更广泛的行业。</p>
</div><h2>The Bottom Line</h2>
<div class="lb-trans"><h2>结论</h2>
</div><p>The most obvious conclusion is that there's been no major change in the business' prospects in recent times, with the analysts holding their earnings forecasts steady, in line with previous estimates. Happily, there were no major changes to revenue forecasts, with the business still expected to grow faster than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.</p>
<div class="lb-trans"><p>最明显的结论是，最近业务前景没有重大变化，分析师们保持了他们的收益预测，与之前的估计一致。令人高兴的是，收入预测没有重大变化，业务仍然预计将比更广泛的行业增长得更快。共识价格目标没有实质性变化，这表明业务的内在价值在最新估计中没有发生重大变化。</p>
</div><p>Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. We have estimates - from multiple Meidensha analysts - going out to 2028, and you can see them free on our platform here.</p>
<div class="lb-trans"><p>考虑到这一点，我们仍然认为，业务的长期发展轨迹对投资者来说更为重要。我们有来自多位明电舍分析师的预测，直到 2028 年，您可以在我们的平台上免费查看。</p>
</div><p>You should always think about risks though. Case in point, we've spotted <strong>1 warning sign for Meidensha</strong> you should be aware of.</p>
<div class="lb-trans"><p>不过，您应该始终考虑风险。举个例子，我们发现了 <strong>明电舍的 1 个警告信号</strong>，您应该注意。</p>
</div>

明电舍株式会社（TSE:6508）第一季度业绩：分析师对今年的预测如下